Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Characteristics of selected anti-CD20 monoclonal antibodies | Download Table
Protéine CD20 pleine longueur exprimée HEK293 avec Nanodisc / DDM / VLP - ACROBiosystems
An Overview of CD20 Monoclonal Antibodies Drugs- CUSABIO
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
Evolution of anti-CD20 monoclonal antibody therapeutics in oncology. - Abstract - Europe PMC
Anti-CD20 monoclonal antibodies: historical and future perspectives | Haematologica
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Anti-mouse CD20 | 18B12-derived | InvivoGen
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies | Scientific Reports
CD20 — Wikipédia
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Antibody drug development: Targeting CD20 and CD3
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Lymphatics | Free Full-Text | A Review of Anti-CD20 Antibodies in the Management of B-Cell Lymphomas
An Overview of CD20 Monoclonal Antibodies Drugs- CUSABIO
iLite® CD20 (+) Target
Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis - touchNEUROLOGY
